Search

Author

Subject

Date issued

Has File(s)

Search Results

Results 331-340 of 2278 (Search time: 0.005 seconds).
  • Authors: Alice, Bernard; Lina Maria, Serna-Higuita; Peter, Martus;  Advisor: -;  Co-Author: - (2023)

    Health-related quality of life after surviving acute respiratory distress syndrome has come into focus in recent years, especially during the coronavirus disease 2019 pandemic.

  • Authors: Ameldina, Ceric; Teresa L., May; Anna, Lybeck;  Advisor: -;  Co-Author: - (2023)

    Sedation and analgesia are recommended during targeted temperature management (TTM) after cardiac arrest, but there are few data to provide guidance on dosing to bedside clinicians. We evaluated differences in patient-level sedation and analgesia dosing in an international multicenter TTM trial to better characterize current practice and clinically important outcomes.

  • Authors: Tobias, Dust; Maximilian J., Hartel; Julian-Elias, Henneberg;  Advisor: -;  Co-Author: - (2023)

    Tibial plateau fractures continue to be a challenging task in clinical practice and current outcomes seem to provide the potential for further improvement. Especially presurgical understanding of the orientation of fracture lines and fracture severity is an essential key to sufficient surgical treatment. The object of this study was to evaluate the reliability of modern axial CT-based classification systems for tibial plateau fractures. In addition, the diagnostic-added value of 3D printing on the classification systems was investigated.

  • Authors: Teodor Svedung, Wettervik; Henrik, Engquist; Timothy, Howells;  Advisor: -;  Co-Author: - (2023)

    Higher intracranial pressure variability (ICPV) has been associated with a more favorable cerebral energy metabolism, lower rate of delayed ischemic neurologic deficits, and more favorable outcome in aneurysmal subarachnoid hemorrhage (aSAH). We have hypothesized that higher ICPV partly reflects more compliant and active cerebral vessels. In this study, the aim was to further test this by investigating if higher ICPV was associated with lower cerebrovascular resistance (CVR) and higher cerebral blood flow (CBF) after aSAH.

  • Authors: Xiaofang, Zeng; Qiong, Liu; Anandharajan, Rathinasabapathy;  Advisor: -;  Co-Author: - (2023)

    Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) belongs to Group 1 pulmonary hypertension. Pulmonary veno-occlusive disease (PVOD), which is characterized by venous system aberrations, has been previously reported in CTD-PAH; however, it has rarely been observed in Sjogren’s syndrome (SS).

  • Authors: Zheng, Xie; Aaron P., Fox;  Advisor: -;  Co-Author: - (2023)

    The α2 adrenergic receptor agonist dexmedetomidine is an important intravenous sedative with analgesic properties. Currently available dexmedetomidine reversal agents, like the α2-receptor antagonist atipamezole, cause serious adverse effects at the large dosages required for effective reversal; they are not used clinically. Without reversal agents, emergence times from dexmedetomidine sedation are slow. In this study we tested the ability of low-dose atipamezole, in combination with caffeine, to reverse dexmedetomidine sedation. The low dose of atipamezole employed should not be associated with unwanted effects.